Pharmacogenomics
β Scribed by Werner Kalow, Urs B. Meyer, Rachel F. Tyndale
- Publisher
- Informa Healthcare
- Year
- 2001
- Tongue
- English
- Leaves
- 416
- Series
- Drugs and the Pharmaceutical Sciences
- Edition
- 1st
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
Univ. of Toronto, Canada. Reference summarizes the history and applications, techniques, and approaches to pharmacogenomics. Discusses new methodologies used to pinpoint genetic variants, latest techniques to achieve phenotypic interpretations, accurate disease gene identification, and more.
π SIMILAR VOLUMES
The term pharmacogenomics is a recent arrival in the literature, but it is a term that anyone interested in pharmacogenetics cannot overlook. The increasing prevalence of the term reflects the progressive transition from genetics to genomics that is taking place in pharmaceutical science. The most f
The occurrence of genetic influences upon one or other drug response was predicted by Sir Archibald Garrot in his 1931 book Inborn Factors in Diseases, and by J.B.S. Haldane in 1949 in an article entitled βDisease and Evolutionβ. Pharmacogenetics, as we know it today, arose as a new scientific entit
In recent years, there have been major developments in the fields of pharmacogenetics and pharmacogenomics, with the potential to make drug treatments in psychiatric medicine more effective. However, improvements in drug efficacy and tolerability, as well as finding the optimal dosage, can only be r